Do DCB Pre-Market Clinical Studies in the US Capture Enough Clinically Relevant Information? - D. Christopher Metzger

↳ This is a section part of Moment: CRT 2017 : Japan FDA - Peripheral Vascular Devices - Appropriate Global Studies for Drug-Coated Balloons and Stents

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Do DCB Pre-Market Clinical Studies in the US Capture Enough Clinically Relevant Information? - D. Christopher Metzger  at CRT 2017.

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Learning Objectives

Other Components in this Moment

Overview
Global Experience with Peripheral DCBs/Stent Studies: Bard - George Papandreou
Global Experience with Peripheral DCBs/Stent Studies: Spectranetics - Patrick Jones
Global Experience with Peripheral DCBs/Stent Studies: Terumo - Ryo Konishi
Do DCB Pre-Market Clinical Studies in the US Capture Enough Clinically Relevant Information? - D. Christopher Metzger
Differences in DCB-Related Patient Characteristics and Clinical Practice Between Japan and the US/Europe - JP Academia View - Hiroyoshi Yokoi
Points To Consider in the Review of Endovascular Treatment Devices: Japanese Regulatory View - Shin Iwamoto
Points To Consider in the Review of Endovascular Treatment Devices: US Regulatory View - Donna Buckley
Loading Simple Education